Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Disease”

3,304 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,304 results

Testing effectiveness (Phase 2)Study completedNCT00006450
What this trial is testing

Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain Tumor
National Cancer Institute (NCI) 120
Not applicableStudy completedNCT04975113
What this trial is testing

The Effects of Progressive Neuromuscular Exercise Program and Taping on Muscle Strength and Pain in Patellofemoral Pain

Who this might be right for
Patellofemoral Pain SyndromeKinesiotapeExercise+1 more
Ankara Yildirim Beyazıt University 30
Not applicableUnknownNCT04955782
What this trial is testing

Abstinence Period and Semen Quality

Who this might be right for
Infertility, Male
ART Fertility Clinics LLC 250
Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Testing effectiveness (Phase 2)Study completedNCT04042558
What this trial is testing

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVEGFR Gene Mutation+2 more
Centre Francois Baclesse 150
Not applicableStudy completedNCT02392078
What this trial is testing

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Who this might be right for
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more
Monteris Medical 1,153
Very early researchEnded earlyNCT03927274
What this trial is testing

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Who this might be right for
Glioma of Brain
H. Lee Moffitt Cancer Center and Research Institute 3
Not applicableStudy completedNCT03613038
What this trial is testing

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Who this might be right for
Amyotrophic Lateral SclerosisParkinson Disease
University of Missouri-Columbia 100
Not applicableStudy completedNCT02285361
What this trial is testing

GIOTRIF rPMS in Korean Patients With NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,272
Not applicableStudy completedNCT01563276
What this trial is testing

Postural Instability in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear PalsyParkinson's Disease
Oregon Health and Science University 36
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Not applicableUnknownNCT01269580
What this trial is testing

Diabetic Foot and Vascular Progenitor Cells

Who this might be right for
DiabetesCritical Limb Ischemia
IRCCS Multimedica 122
Not applicableStudy completedNCT01923103
What this trial is testing

Natural Disease Progress of Dupuytren Disease

Who this might be right for
Dupuytren ContractureDisease Progression
University Medical Center Groningen 261
Large-scale testing (Phase 3)UnknownNCT00815256
What this trial is testing

Safety and Effectiveness of Collagen Cross Linking in Progressive Mild and Moderate Keratoconus

Who this might be right for
Cornea DegenerationProgressive Keratoconus
Federal University of São Paulo 15
Not applicableNot Yet RecruitingNCT07116902
What this trial is testing

Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of California, San Francisco 50
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Not applicableStudy completedNCT02889146
What this trial is testing

Progressive Mobility Program and Technology to Improve the Level of Physical Activity and Functionality of ICU Patients

Who this might be right for
Critical IllnessMuscle Weakness
University of Sao Paulo General Hospital 98
Early research (Phase 1)Study completedNCT01171469
What this trial is testing

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Who this might be right for
Brain TumorGlioblastomaMedulloblastoma+2 more
Masonic Cancer Center, University of Minnesota 8
Large-scale testing (Phase 3)Study completedNCT06122662
What this trial is testing

AMX0035 and Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear PalsyPSPNeurodegenerative Diseases+1 more
Amylyx Pharmaceuticals Inc. 139
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Load More Results